Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -2.83 |
| peg ratio | 0.03 |
| price to book ratio | 6.79 |
| price to sales ratio | 933.29 |
| enterprise value multiple | -3.36 |
| price fair value | 6.79 |
profitability ratios | |
|---|---|
| gross profit margin | 0.14% |
| operating profit margin | -33065.92% |
| pretax profit margin | -32901.78% |
| net profit margin | -32973.66% |
| return on assets | -148.74% |
| return on equity | -203.91% |
| return on capital employed | -219.29% |
liquidity ratio | |
|---|---|
| current ratio | 2.99 |
| quick ratio | 2.99 |
| cash ratio | 2.62 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 2,105.09 |
| days of payables outstanding | 6,195.88 |
| cash conversion cycle | -4,090.79 |
| receivables turnover | 0.17 |
| payables turnover | 0.06 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.09 |
| long term debt to capitalization | 0.04 |
| total debt to capitalization | 0.08 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -27.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.80 |
| cash per share | 0.45 |
| operating cash flow per share | -0.79 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -27.40 |
| short term coverage ratios | -178.22 |
| capital expenditure coverage ratio | -977.40 |
Frequently Asked Questions
Gain Therapeutics, Inc. (GANX) published its most recent earnings results on 14-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Gain Therapeutics, Inc. (NASDAQ:GANX)'s trailing twelve months ROE is -203.91%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Gain Therapeutics, Inc. (GANX) currently has a ROA of -148.74%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
GANX reported a profit margin of -32973.66% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.99 in the most recent quarter. The quick ratio stood at 2.99, with a Debt/Eq ratio of 0.09.